A detailed history of Deseret Mutual Benefit Administrators transactions in Abb Vie Inc. stock. As of the latest transaction made, Deseret Mutual Benefit Administrators holds 9,764 shares of ABBV stock, worth $1.9 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
9,764
Previous 8,995 8.55%
Holding current value
$1.9 Million
Previous $1.64 Million 2.26%
% of portfolio
0.78%
Previous 0.82%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $119,033 - $139,004
769 Added 8.55%
9,764 $1.67 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $79,590 - $90,685
498 Added 5.86%
8,995 $1.64 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $337,120 - $379,676
-2,450 Reduced 22.38%
8,497 $1.32 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $119,563 - $138,411
895 Added 8.9%
10,947 $1.63 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $307,555 - $382,732
2,321 Added 30.02%
10,052 $1.35 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $423,707 - $487,962
2,930 Added 61.03%
7,731 $1.23 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $396,534 - $475,549
-2,867 Reduced 37.39%
4,801 $776,000
Q3 2022

Nov 03, 2022

SELL
$134.21 - $153.93 $20,668 - $23,705
-154 Reduced 1.97%
7,668 $1.03 Million
Q2 2022

Aug 05, 2022

BUY
$137.62 - $174.96 $191,154 - $243,019
1,389 Added 21.59%
7,822 $1.2 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $202,589 - $251,356
-1,535 Reduced 19.26%
6,433 $1.04 Million
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $561,644 - $710,642
-5,228 Reduced 39.62%
7,968 $1.08 Million
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $464,329 - $527,083
4,364 Added 49.41%
13,196 $1.42 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $929,214 - $1.04 Million
8,832 New
8,832 $995,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Deseret Mutual Benefit Administrators Portfolio

Follow Deseret Mutual Benefit Administrators and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deseret Mutual Benefit Administrators, based on Form 13F filings with the SEC.

News

Stay updated on Deseret Mutual Benefit Administrators with notifications on news.